ATLAS: A Phase 2, Open-label Study of Rucaparib in Patients with Locally Advanced or Metastatic Urothelial Carcinoma

IRB/UVA Tracking #
20610
Contact First Name

Julio Torres

Contact Email
Contact Phone
Phase
II
Primary purpose
Treatment
Cancer PI
Robert Dreicer
Status
OPEN TO ACCRUAL